Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 38,422,385
- Share change
- -224,871
- Total reported value
- $1,492,282,987
- Put/Call ratio
- 144%
- Price per share
- $38.84
- Number of holders
- 104
- Value change
- -$15,747,693
- Number of buys
- 54
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ATP Life Science Ventures, L.P. |
13F
|
Company |
30%
|
17,161,713
|
$1,062,825,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
6.3%
|
3,600,975
|
$223,008,000 | — | 31 Dec 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
6.2%
|
3,544,248
|
$219,495,000 | — | 31 Dec 2020 | |
| Redmile Group, LLC |
13F
|
Company |
4.7%
|
2,686,234
|
$166,358,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
1,660,060
|
$102,807,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
1,606,268
|
$99,475,000 | — | 31 Dec 2020 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
2.6%
|
1,470,841
|
$91,089,000 | — | 31 Dec 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.5%
|
1,437,807
|
$89,043,000 | — | 31 Dec 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.7%
|
968,811
|
$59,999,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
749,626
|
$46,424,000 | — | 31 Dec 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
671,978
|
$41,616,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
576,970
|
$35,731,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.75%
|
434,108
|
$26,884,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
271,165
|
$16,793,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.43%
|
250,000
|
$15,483,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
199,970
|
$12,384,000 | — | 31 Dec 2020 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.22%
|
126,303
|
$7,822,000 | — | 31 Dec 2020 | |
| Casdin Capital, LLC |
13F
|
Company |
0.21%
|
120,000
|
$7,432,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
115,997
|
$7,184,000 | — | 31 Dec 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.16%
|
92,500
|
$5,729,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.13%
|
76,928
|
$4,764,000 | — | 31 Dec 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.12%
|
66,913
|
$4,145,000 | — | 31 Dec 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.1%
|
60,000
|
$3,716,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
54,235
|
$3,358,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
51,110
|
$3,165,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
39,813
|
$2,465,000 | — | 31 Dec 2020 | |
| AVIVA PLC |
13F
|
Company |
0.06%
|
36,753
|
$2,276,000 | — | 31 Dec 2020 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.06%
|
34,200
|
$2,118,000 | — | 31 Dec 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
31,341
|
$1,941,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
25,329
|
$1,568,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
25,000
|
$1,548,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
24,940
|
$1,545,000 | — | 31 Dec 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.03%
|
20,000
|
$1,239,000 | — | 31 Dec 2020 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.03%
|
20,000
|
$1,239,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
18,800
|
$1,164,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
18,764
|
$1,162,000 | — | 31 Dec 2020 | |
| HighVista Strategies LLC |
13F
|
Company |
0.03%
|
17,668
|
$1,094,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
17,400
|
$1,078,000 | — | 31 Dec 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
17,300
|
$1,071,000 | — | 31 Dec 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
15,672
|
$971,000 | — | 31 Dec 2020 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
14,100
|
$873,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
13,157
|
$815,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
11,100
|
$687,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
10,964
|
$679,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
9,209
|
$570,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.02%
|
8,990
|
$557,000 | — | 31 Dec 2020 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.02%
|
9,200
|
$544,456 | — | 31 Dec 2020 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
8,900
|
$523,000 | — | 31 Dec 2020 | |
| ProShare Advisors LLC |
13F
|
Company |
0.01%
|
8,339
|
$516,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
8,030
|
$497,000 | — | 31 Dec 2020 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q1 2021
As of 31 Mar 2021,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,422,385 shares.
The largest 10 holders included
ATP Life Science Ventures, L.P., RTW INVESTMENTS, LP, FMR LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, FEDERATED HERMES, INC., and STATE STREET CORP.
This page lists
104
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
93
Q1 2021 holders
104
Holder diff
11
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.